Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes Published, JLR Papers in Press, October 1, 2006.

Diseases such as obesity, diabetes, and atherosclerosis result from multiple genetic and environmental factors, and importantly, interactions between genetic and environmental factors. Identifying susceptibility genes for these diseases using genetic and genomic technologies is accelerating, and the expectation over the next several years is that a number of genes will be identified for common diseases. However, the identification of single genes for disease has limited utility, given that diseases do not originate in complex systems from single gene changes. Further, the identification of single genes for disease may not lead directly to genes that can be targeted for therapeutic intervention. Therefore, uncovering single genes for disease in isolation of the broader network of molecular interactions in which they operate will generally limit the overall utility of such discoveries. Several integrative approaches have been developed and applied to reconstructing networks. Here we review several of these approaches that involve integrating genetic, expression, and clinical data to elucidate networks underlying disease. Networks reconstructed from these data provide a richer context in which to interpret associations between genes and disease. Therefore, these networks can lead to defining pathways underlying disease more objectively and to identifying biomarkers and more-robust points for therapeutic intervention.

[1]  Judea Pearl,et al.  Chapter 2 – BAYESIAN INFERENCE , 1988 .

[2]  Judea Pearl,et al.  Probabilistic reasoning in intelligent systems - networks of plausible inference , 1991, Morgan Kaufmann series in representation and reasoning.

[3]  G. Chaudhuri,et al.  Estrogens and atherosclerosis. , 1997, Annual review of pharmacology and toxicology.

[4]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[5]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[6]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[7]  Russell D. Wolfinger,et al.  The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster , 2001, Nature Genetics.

[8]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[9]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[10]  Kai Stühler,et al.  Genetic analysis of the mouse brain proteome , 2002, Nature Genetics.

[11]  L. Kruglyak,et al.  Genetic Dissection of Transcriptional Regulation in Budding Yeast , 2002, Science.

[12]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[13]  G. Churchill,et al.  Variation in gene expression within and among natural populations , 2002, Nature Genetics.

[14]  Rachel B. Brem,et al.  Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors , 2003, Nature Genetics.

[15]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[16]  E. Zerhouni The NIH Roadmap , 2003, Science.

[17]  H. Sauer,et al.  The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia. , 2004, Journal of psychiatric research.

[18]  C. Molony,et al.  Genetic analysis of genome-wide variation in human gene expression , 2004, Nature.

[19]  A. Goldberg A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women. , 2004, The American journal of cardiology.

[20]  Jilly F. Evans,et al.  The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm , 2004, Nature Medicine.

[21]  E. Schadt,et al.  Genomic analysis of metabolic pathway gene expression in mice , 2005, Genome Biology.

[22]  E. Schadt,et al.  Genetic inheritance of gene expression in human cell lines. , 2004, American journal of human genetics.

[23]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[24]  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004 .

[25]  Lan V. Zhang,et al.  Evidence for dynamically organized modularity in the yeast protein–protein interaction network , 2004, Nature.

[26]  A. G. Roseberry,et al.  Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin , 2004, Science.

[27]  J. Zhu,et al.  An integrative genomics approach to the reconstruction of gene networks in segregating populations , 2004, Cytogenetic and Genome Research.

[28]  M. Gerstein,et al.  Genomic analysis of regulatory network dynamics reveals large topological changes , 2004, Nature.

[29]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[30]  Andrew I Su,et al.  Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics' , 2005, Nature Genetics.

[31]  E. Petretto,et al.  Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease , 2005, Nature Genetics.

[32]  Robert W. Williams,et al.  Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function , 2005, Nature Genetics.

[33]  Michael K. Skinner,et al.  Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility , 2005, Science.

[34]  Marc Vidal,et al.  Predictive models of molecular machines involved in Caenorhabditis elegans early embryogenesis , 2005, Nature.

[35]  E. Schadt Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits. , 2005, Current opinion in biotechnology.

[36]  Eric E Schadt,et al.  Cis-acting expression quantitative trait loci in mice. , 2005, Genome research.

[37]  Eric E Schadt,et al.  Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. , 2005, Genomics.

[38]  John D. Storey,et al.  Significance analysis of time course microarray experiments. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E E Schadt,et al.  Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits , 2005, Nature Genetics.

[40]  Joshua T. Burdick,et al.  Mapping determinants of human gene expression by regional and genome-wide association , 2005, Nature.

[41]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[42]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[43]  S. Friend,et al.  Embracing Complexity, Inching Closer to Reality , 2005, Science's STKE.

[44]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[45]  S. Horvath,et al.  Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks , 2006, BMC Genomics.

[46]  Manjunatha Jagalur,et al.  Causal inference of regulator-target pairs by gene mapping of expression phenotypes , 2005, BMC Genomics.

[47]  G. Churchill,et al.  Quantitative trait locus analysis for obesity reveals multiple networks of interacting loci , 2006, Mammalian Genome.

[48]  S. Hunt,et al.  Genome-Wide Associations of Gene Expression Variation in Humans , 2005, PLoS genetics.

[49]  Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study , 2005 .

[50]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[51]  Vera Regitz-Zagrosek,et al.  Therapeutic implications of the gender-specific aspects of cardiovascular disease , 2006, Nature Reviews Drug Discovery.

[52]  E E Schadt,et al.  Novel integrative genomics strategies to identify genes for complex traits , 2006, Animal genetics.

[53]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[54]  Aiqing He,et al.  Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids , 2006, Proceedings of the National Academy of Sciences.

[55]  David M Nathan,et al.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. , 2006, The New England journal of medicine.

[56]  S. Horvath,et al.  Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals. , 1967, British Journal of Cancer.

[57]  J. Lamb,et al.  Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes , 2006, Journal of neurochemistry.

[58]  C. Kendziorski,et al.  Statistical Methods for Expression Quantitative Trait Loci (eQTL) Mapping , 2006, Biometrics.

[59]  Mark G. Kosowski,et al.  Gender-specific care of the patient with diabetes: review and recommendations. , 2006, Gender medicine.

[60]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[61]  A. Parker,et al.  Delivery of RNA Interference , 2006, Cell cycle.

[62]  Dan Nettleton,et al.  Genetic Regulation of Gene Expression During Shoot Development in Arabidopsis , 2006, Genetics.

[63]  A. Arnold,et al.  Tissue-specific expression and regulation of sexually dimorphic genes in mice. , 2006, Genome research.

[64]  D. Pe’er,et al.  Identifying regulatory mechanisms using individual variation reveals key role for chromatin modification , 2006, Proceedings of the National Academy of Sciences.

[65]  R. Kishony,et al.  Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.

[66]  E. Schadt,et al.  Genetic and Genomic Analysis of a Fat Mass Trait with Complex Inheritance Reveals Marked Sex Specificity , 2006, PLoS genetics.

[67]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[68]  Yan Cui,et al.  Integrative genetic analysis of transcription modules: towards filling the gap between genetic loci and inherited traits. , 2006, Human molecular genetics.

[69]  F. Blasi,et al.  Anxiety and depression in COPD patients: The roles of gender and disease severity. , 2006, Respiratory medicine.

[70]  F. Hu,et al.  A Common Genetic Variant Is Associated with Adult and Childhood Obesity , 2006, Science.

[71]  Jeffrey T Leek,et al.  The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments. , 2007, Biostatistics.